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Contribution of congenital disorders 
to neonatal mortality in South Africa
To the Editor: The article ‘Reducing neonatal deaths in South 
Africa: Progress and challenges’[1] in the March 2018 SAMJ Maternal 
and Child Health Supplement reviews recent neonatal estimates, 
causes and ways of reducing preventable deaths in this age category 
in the context of the Sustainable Development Goals.[2] While the 
article acknowledges the increasing contribution of ‘congenital 
anomalies’ as a cause of neonatal death, it fails to acknowledge 
the proportion of ‘congenital disorders’ (CDs) as a collective. No 
definition is included, but the literature defines congenital anoma lies 
as macroscopic morphological anomalies present at birth,[3,4] refer ring 
to clinically obvious structural abnormalities as classified in Chapter 
XVII: ‘Congenital malformations, deformations and chromosomal 
abnormalities’ of the International Statistical Classification of Diseases 
and Related Health Problems (ICD-10).[5] This excludes ‘non-
syndromic congenital disability (intellectual, physical, visual and 
auditory disability and epilepsy), common single gene disorders such 
as the haemoglobin disorders, glucose-6 phosphate dehydrogenase 
deficiency, cystic fibrosis, oculocutaneous albinism, spinal muscular 
atrophy and inborn errors of metabolism’[4] and teratogens. These 
are distributed throughout the ICD-10 system, accounting for a 
third of CDs globally.[6] Presenting only a subset of CDs to represent 
the totality of CDs has implications, particularly for cause-of-death 
rankings and planning of services and interventions.
While the role of congenital anomalies is indicated as a notable 
cause of death in neonates in South Africa (SA), ranking fourth after 
prematurity, intrapartum-related events and infection, CDs may 
rank higher as a cause of death. CDs are internationally defined as 
abnormalities in structure or function present from birth, including 
inborn errors in metabolism.[4] This classification disparity is further 
evidenced by the average baseline birth prevalence rates of congenital 
anomalies of 20 per 1 000 live births[7] v. that of CDs at >39.7 per 
1 000 live births.[6,8] Interestingly, contrary to the article text, data in 
Fig.  5 showing causes of neonatal deaths per level of care indicate 
that congenital anomalies rank third as a cause of neonatal death at 
an overall 8.8%, ahead of infection at 7.7%, with the greatest disparity 
between these two causes of death at district hospitals.[1]
Non-diagnosis or misdiagnosis resulting in the cause of death 
being incorrectly attributed also contributes to underreporting of 
CDs as a cause of death. Honein et al.[9] report CDs as being twice 
as common in preterm infants (24 - 36 weeks) as in term infants, 
and five times more likely in very preterm infants (24 - 31 weeks), 
with 16% of very preterm births having a CD. Similarly, a portion of 
deaths assigned to intrapartum-related events may be due to severe 
congenital cerebral palsy (CP). The Centers for Disease Control and 
Prevention indicates that 85 - 90% of CP is congenital,[10] of which an 
estimated 30 - 40% has a genetic aetiology, with birth asphyxia only 
accounting for 10 - 15% of all CP cases.[11-16] Congenital syphilis, a 
CD by definition, contributes a minimum of 3% of neonatal deaths[17] 
and together with other congenital (TORCH) infections (which 
include toxoplasmosis, other (syphilis, varicella-zoster, parvovirus 
b19), rubella, cytomegalovirus and herpes) may also be allocated to 
the infections cause of death category.[8] This proportion is probably 
an underestimate, since diagnosis of congenital syphilis in neonates 
is more difficult than in pregnant women, with adverse pregnancy 
outcomes in 38% of cases of maternal infection, including neonatal 
death in 7% of cases.[18]
Neonates born with a CD have an increased susceptibility to 
infection in certain instances, with the infection being more ‘obvious’ 
and more likely to be diagnosed and assigned as the cause of death 
than the underlying CD in cases of comorbidity.[19,20] The lack of a 
newborn screening policy and top-to-toe examination of the infant 
prior to discharge further contributes to non-diagnosis and the 
inaccurate assessment of the contribution of CDs to the burden of 
disease.[8,19,21,22]
With a significant proportion of under-5 deaths occurring during 
the neonatal period, comprehensively addressing CDs as a cause of 
neonatal deaths in SA is now an imperative. World Health Assembly 
(WHA) Resolution 63.17 of 2010[23] recognised the importance 
of CDs as a cause of stillbirths and neonatal mortality and their 
contribution to the failure in attaining Millennium Development 
Goal 4. The same WHA recommendations must now be heeded if the 
SGD targets set for 2030 to end preventable deaths in this age group 
are to be met.[2,23]
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